« Previous
Next »
Titles
- A resource guide for using Medicare’s enrollment race and ethnicity data1
- ACF should improve oversight of head start to better protect children’s safety1
- Addressing the direct care workforce shortage: a bipartisan call to action1
- Advancing primary prevention in human services. Key considerations for administrators and practitioners1
- Advancing primary prevention in human services. Key considerations for policy designers and funding partners1
- Advancing primary prevention in human services. Opportunities for people with lived experience1
- Advancing research on intersections of child welfare and Medicaid using linked data from the CCOULD project1
- Adverse events in hospitals. A quarter of Medicare patients experienced harm in October 20181
- Adverse events toolkit. Clinical guidance for identifying harm1
- Adverse events toolkit. Medical record review methodology1
- Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate1
- An estimated 91 percent of nursing home staff nationwide received the required COVID-19 vaccine doses, and an estimated 56 percent of staff nationwide received a booster dose1
- An insurance profile of rural America: chartbook : key facts about insurance coverage and healthcare access in rural America1
- Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry1
- Antimicrobial susceptibility test (AST) system devices: updating breakpoints in device labeling : guidance for industry and Food and Drug Administration staff1
- Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees1
- Application of human factors engineering principles for combination products: questions and answers : guidance for industry and FDA staff1
- Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff1
- Behavioral health diagnoses and treatment services for children and youth involved with the child welfare system1
- Benefit-risk assessment for new drug and biological products: guidance for industry1